Tetra Cortisone

Quick links

Choose a section

Quick links to important sections

Advertisements

Tetra Cortisone

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Tetra Cortisone

Quick Facts

Property Description
Active Ingredients Hydrocortisone, Tetracycline
Pharmacological Class Combination Corticosteroid and Antibiotic
Form Topical Ointment, Topical Cream, Ophthalmic Preparation
Route of Administration Topical (Local application)
Origin Synthetic/Derived Substances

What is the Defining Pharmaceutical Identity of Tetra Cortisone?

Tetra Cortisone is fundamentally a recognized Fixed-Dose Combination (FDC) medicinal entity, classified within the high-level pharmacological class of a Combination Corticosteroid and Antibiotic. This identity is established by the simultaneous presence of these two distinct therapeutic classes within a single preparation. This specific FDC structure, widely supported by pharmacological studies, is intended to provide a comprehensive topical strategy. The preparation is designated for local application, with its typical route of administration being Topical (for skin) or specialized Ophthalmic applications for the eye surface.

Composition and Source: Is Tetra Cortisone a Steroid-Antibiotic Blend?

Yes, Tetra Cortisone is an established blend featuring the mild-potency steroid Hydrocortisone and the broad-spectrum antibiotic Tetracycline as its core active ingredients (INN). The Hydrocortisone component is a glucocorticoid steroid that primarily functions as a potent anti-inflammatory agent. The Tetracycline component belongs to the tetracycline group of antibiotics, which are clinically recognized for their ability to inhibit bacterial protein synthesis. Both components are synthetic chemical substances or derivatives. Its composition differs from single-component products by offering dual action in a single Topical Ointment or Topical Cream form.

General Purpose: What is the Overall Benefit of this Dual-Action Agent?

The overall benefit of the Tetra Cortisone preparation is its ability to provide simultaneous anti-inflammatory and antibacterial action, creating an efficient, two-pronged therapeutic strategy. The Hydrocortisone works to quickly calm localized symptoms like redness and swelling by initiating an immunosuppressive effect. Concurrently, the Tetracycline component exerts a bacteriostatic effect, inhibiting the growth of susceptible bacteria. This combination is strategically purposed for managing conditions characterized by coexisting irritation and microbial presence.

Regulatory References

  1. DailyMed Label for Oxytetracycline and Hydrocortisone FDC
  2. DailyMed Label for Tetracycline (Mechanism of Action)
Advertisements

What side effects are possible with Tetra Cortisone?

Possible Side Effects and Safety Information

Adverse Reaction Scope

The safety profile of the combination (Hydrocortisone/Tetracycline) is characterized by local application site reactions and the potential for systemic effects primarily due to the corticosteroid component. The listed effects are classified according to frequency and the body system affected, based on official regulatory documents.

Classification Examples of Reactions
Common / Local Burning, itching, irritation, dryness, folliculitis
Uncommon / Rare (Skin) Skin atrophy (thinning), striae, hypopigmentation
Serious / Systemic HPA axis suppression, Cushing's syndrome, Intracranial Hypertension (in children)
Serious / Ocular Glaucoma, posterior subcapsular cataracts (with prolonged ophthalmic use)

System-Organ Classes and Regulatory Constraints

The most affected area is the Skin and Subcutaneous Tissue. Serious effects involve the Endocrine System (HPA axis suppression) and Eye Disorders (for the ophthalmic preparation).

Time- and Duration-Related Safety Patterns show that while common local irritation may occur at the start of use, serious reactions like skin atrophy and systemic effects are associated with prolonged or long-term use or use on large surface areas.

Population-Specific Safety: Pediatric patients are documented as being at greater risk for systemic effects, including HPA axis suppression and Intracranial Hypertension, due to a larger skin surface area-to-body mass ratio.

Safety-Related Restrictions: The official labeling notes that the corticosteroid component may mask or enhance existing infection, and prolonged use may lead to the overgrowth of non-susceptible organisms.

Summary

These safety classifications structure the understanding of risk by separating transient local effects from serious systemic or duration-dependent risks, focusing heavily on the constraints related to corticosteroid absorption and prolonged use.

Advertisements

Overdose and Emergency Response

Overdose Risk and Symptoms

Acute overdose from a single large ingestion of Tetra Cortisone is considered an unlikely event to cause a severe clinical syndrome. Management in this specific situation is typically supportive and focused on symptoms. No dedicated antidote is available for acute overdose.

The greater concern lies with chronic overuse or prolonged exposure to doses higher than prescribed. This pattern of use can lead to serious conditions, including the development of signs consistent with Cushing's syndrome (such as moon face and significant weight gain) and the suppression of the body's natural adrenal function (HPA axis).

Manifestations of chronic overuse may affect multiple body systems, leading to fluid retention, electrolyte imbalances (e.g., potassium loss), elevated blood pressure, and psychological disturbances (e.g., mood swings, insomnia, depression, or psychosis).

When to Seek Immediate Medical Help

Immediate medical attention should be sought if you or a caretaker observe any of the following signs:

  • Severe psychological symptoms, including depressed mood, suicidal thoughts, or psychosis.
  • Symptoms of a sudden loss of adrenal function (adrenocortical insufficiency), particularly if the medication has been recently stopped or the patient is under severe stress. Symptoms can include profound fatigue, persistent nausea, vomiting, dizziness, or fainting.
  • Infants born to mothers who received substantial doses during pregnancy should be carefully monitored and assessed for signs of hypoadrenalism.

In all cases of suspected overdose or concerning symptoms, contact emergency medical services or a poison control center immediately. The treatment will be supportive, managing symptoms and monitoring physiological systems.

Advertisements

Therapeutic Uses of Tetra Cortisone

What Tetra Cortisone Treats: Main Uses and Benefits

This medication is commonly used across conditions presenting with acute episodes where inflammation, such as that associated with eczema or dermatitis, has become complicated by a secondary bacterial infection. This combination may be relevant for managing symptom clusters that become intense or disruptive, including intense redness, swelling, and severe itching, alongside symptoms related to physical discomfort. The combination is applied across domains where additional symptomatic support is needed.

It is typically used in clinical settings that involve acute or unstable symptom patterns, such as secondarily infected insect bites, certain types of exudative intertrigo, bacterial conjunctivitis, and Trachoma. It provides support that helps ease the overall symptom burden during periods of heightened symptoms. Furthermore, it is considered relevant in contexts involving specific symptomatic management for certain patient groups.


Quick Fact: Support for Symptom Clusters

Category Typical Use Contexts
Symptom Focus Intense Redness, Swelling, Itching, Pain, Discharge
Condition Types Infected Eczema, Contact Dermatitis with infection, Bacterial Conjunctivitis
Primary Benefit Helps ease the overall symptom load

Regulatory References

  1. DailyMed NLM Drug Label for Oxytetracycline/Hydrocortisone
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Tetra Cortisone?

Eligibility for Tetra Cortisone (a combination of Hydrocortisone and Oxytetracycline) is strictly defined by regulatory bodies and must adhere to specific population and clinical constraints.

Contraindicated Populations (Must Not Use)

This medication is absolutely prohibited for several groups:

  • Hypersensitivity: Patients with a known allergy to Oxytetracycline, Hydrocortisone, or any other ingredient in the formulation.
  • Infection Type: Individuals with viral diseases (such as Herpes Simplex, Vaccinia, or Varicella), fungal diseases, or mycobacterial infections (Tuberculosis) affecting the area of application.
  • Age and Development: Infants and small children are contraindicated due to the risk of developmental effects from the tetracycline component.
  • Reproductive Status: Pregnant women and nursing mothers must not use this medication.

Age-Related and Conditional Eligibility

Population Eligibility Status (Regulatory)
Children up to 12 years Not Recommended (for certain formulations)
Perforated Eardrum Not Recommended (for otic use)
Renal/Hepatic Impairment No special precautions documented (for topical use)

Use is generally reserved for adults with corticosteroid-responsive inflammation complicated by a susceptible secondary bacterial infection, as formally documented in prescribing information.

Advertisements

What should I know about interactions with other medicines?

The official interaction profile for Tetra Cortisone is structured around the documented systemic risks associated with its active components, Hydrocortisone and Tetracycline.

Official Interaction Restrictions

Certain medicinal products are formally documented as strictly contraindicated with the tetracycline component. This includes Systemic Retinoids (such as Isotretinoin), due to the associated risk of Intracranial Hypertension, and Methoxyflurane, which carries a documented risk of fatal renal toxicity.

Exposure-Modifying Substances

Co-administration with Other Corticosteroid-containing products may result in a clinically significant interaction. This is due to the potential for additive systemic glucocorticoid exposure, which heightens the risk of Hypothalamic-Pituitary-Adrenal (HPA) axis suppression.

Pharmacodynamic Interactions

Combining the product with other Phototoxic Agents may cause an additive risk of photosensitivity. Regulatory information notes that the tetracycline component may interfere with the bactericidal action of Penicillins and is documented to depress plasma prothrombin activity, which is a consideration for patients receiving Anticoagulants.

Population-Specific Notes

The risk of exposure-related interactions, particularly HPA-axis suppression, is officially noted as being greater in Pediatric Patients and patients with underlying Hepatic Impairment.

Advertisements

Mechanism of Action

How Tetra Cortisone Works

Tetra Cortisone, a synthetic corticosteroid derivative, exerts its primary action by functioning as an agonist for the intracellular glucocorticoid receptor (GR). Upon binding, the activated ligand-receptor complex translocates into the cell nucleus. This complex then modulates the transcription of specific target genes through two processes: transactivation (increasing expression of anti-inflammatory proteins) and transrepression (inhibiting the expression of pro-inflammatory mediators).

This early molecular sequence results in the suppression of inflammatory cascade pathways by reducing the synthesis of cytokines and chemokines, such as ICAM-1 and ELAM-1. At the physiological level, this cascade limits the recruitment and migration of immune cells, including neutrophils and fibroblasts, to affected sites, leading to the attenuation of mediator activity and subsequent modulation of physiological hyper-responsiveness.

Additionally, the drug engages rapid, non-genomic mechanisms involving direct interaction with cell membranes or membrane-bound receptors, which immediately modify certain intracellular signaling systems, contributing to rapid cellular effects.

Advertisements

Dosage and Administration Information

How to Use Tetra Cortisone — Official Administration Guidelines

Administration of Tetra Cortisone (a generalized glucocorticoid) must be individualized based on the specific condition and the patient's response. The goal is to use the lowest possible dosage that maintains an adequate clinical response. Sudden discontinuation of the medication, particularly after long-term or high-dose therapy, is strictly prohibited and requires a gradual dosage reduction (taper) under medical supervision to avoid withdrawal symptoms.


Administration Details

Feature Requirement
Route of Administration Oral (tablet, granules), Intravenous (IV), Intramuscular (IM), or Topical (e.g., cream).
Dosing Schedule Highly variable; determined by the prescriber. Parenteral doses may need repetition every 4 to 6 hours for sustained high blood levels in emergency use.
Timing in relation to meals Oral tablets should be taken with food or milk to prevent gastrointestinal irritation. Some modified-release formulations may require administration 30 minutes before food on awakening.
Preparation Parenteral forms (for IV/IM) must be reconstituted using a proper diluent before administration. Oral granules must be swallowed whole without chewing or crushing.
Special Conditions Patients under unusual stress (e.g., surgery, infection) may require a temporarily increased dose of rapidly acting corticosteroid. Topical products should not be covered with occlusive dressings unless specifically directed by a healthcare professional.
Missed Dose Rule If a dose is missed, take it as soon as possible. If it is almost time for the next dose, skip the missed dose and continue the regular schedule. Do not double the dose.

Age-Specific Use

In pediatric patients, the dose is generally determined by the severity of the condition and patient response, not solely by age or body weight. Long-term therapy in children must be monitored carefully, as it may interfere with growth and development.

Advertisements

Recent Clinical Evidence

Evidence for Use in Infected Inflammatory Skin Conditions

Research was studied for use in conditions characterized by fluctuating manifestations and complicated by a secondary bacterial presence. The most significant research available consists of short-term Randomized Controlled Trials (RCTs) and systematic reviews, which examined the topical combination in adults and children with clinically suspected infected inflammatory skin conditions. The research monitored outcomes related to physical discomfort using validated severity scoring scales. Trials reported findings describe patterns observed in the studies related to clinical severity scores. However, comparative evidence against the topical corticosteroid component used alone is lacking consistency across various studies.


Long-Term Studies and Follow-Up Data

Studies conducted during periods of increased symptom activity have primarily explored short-term symptom changes over defined time intervals. Follow-up durations were limited, with primary measurements taken within the first one to four weeks of application. Long-term effects are not fully established or fully characterized in existing systematic reviews regarding the durability of effect following the cessation of application. The limited information for long-term outcomes means it is not fully established how patterns observed in the study period translate to long-term management.


Evidence in Special Populations

Specific research was evaluated in certain groups, particularly young patients. Studies focusing on episodes where symptoms become more noticeable was observed in cohorts of children with clinically suspected infected eczema. Data for certain groups remain insufficient, as results apply only to the populations studied within the trial parameters.


Evidence Quality and Consistency

The overall evidence supporting the research context of this combination is categorized as Moderate. Crucially, the evidence highlights what is known and what is still uncertain regarding how outcomes differ when the combination is compared to the steroid component used alone. Research has explored whether the addition of the antibiotic component influences outcomes in eczema that is not overtly infected, and findings were mixed regarding this specific research question. The lack of a standardized definition of infected eczema creates heterogeneity across the body of research.

Key Studies & References

  1. Summary of Evidence - Topical Antibiotics for Infected Dermatitis: A Review of the Clinical Effectiveness and Guidelines
  2. Label: terra-cortril- oxytetracycline hydrochloride and hydrocortisone acetate suspension - DailyMed (Regulatory context for combination)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Tetra Cortisone (FAQ)


Q: Can Tetra Cortisone affect blood sugar levels?

The active ingredient Hydrocortisone is a glucocorticoid, a type of medicine documented to have profound and varied metabolic effects. This action is involved in regulating how the body uses glucose (sugar).

Official information indicates that systemic exposure to this component may be associated with an increased risk of elevated blood sugar levels or diabetes.


Q: What types of food or drinks might interact with Tetra Cortisone?

Regulatory information advises caution regarding certain food and mineral products due to the tetracycline component.

Food, particularly dairy products, and supplements containing minerals like calcium, iron, or magnesium, can interfere with the absorption of tetracycline, potentially making it less effective. Regulatory information typically advises that administration of the drug should be separated from these products to maintain effectiveness.


Q: What is the general safety classification of Tetra Cortisone (e.g., in pregnancy or breastfeeding)?

Regulatory documents state that the tetracycline component is known to cross the placenta and may have toxic effects on a developing fetus.

Due to the risks associated with this component, official documentation indicates the medication is generally prohibited for use by pregnant women or nursing mothers.


Q: Why are there warnings about vision changes with Tetra Cortisone?

Warnings about vision changes relate to the potential systemic effects of both active components.

The Hydrocortisone component, especially with prolonged use, is associated with serious ocular issues such as glaucoma and cataracts. Additionally, the Tetracycline component is linked to a risk of Increased Intracranial Pressure, which can cause visual disturbances.


Q: Is it okay to have a small amount of alcohol while using Tetra Cortisone?

Regulatory information for certain medications containing tetracycline components notes that the use of alcohol is usually not recommended.

Patients are advised that the combination of alcohol and medication may heighten side effects or interfere with the drug’s effectiveness. Consultation with a healthcare professional regarding alcohol consumption is consistent with official guidance.


Q: Why do official documents mention 'risk of infection' when discussing Tetra Cortisone?

This risk is associated with the Hydrocortisone component, which belongs to the class of corticosteroids.

Corticosteroids act as immunosuppressants, meaning they can lower the body’s immune response. Glucocorticoids are documented to increase the risk of severe infections or may mask an existing infection.


Q: Do I need a prescription to get Tetra Cortisone?

Yes, because this combination includes the active ingredient Tetracycline, which is categorized as an antibiotic.

Antibiotic components are regulated as prescription-only medicines in most official regulatory documents, making the combination product unavailable over-the-counter.


Q: Can Tetra Cortisone cause weight gain?

Weight gain is listed in regulatory-sourced materials as a possible serious side effect associated with systemic exposure to the corticosteroid component.

Regulatory documents state that systemic effects, including the potential for weight gain, are associated with prolonged or high-dose use of corticosteroids.


Q: Are headaches a common side effect of Tetra Cortisone?

Headache is listed as a neurological side effect in the prescribing information for the systemic form of the Hydrocortisone component.

Official information documents potential systemic side effects, and awareness of all documented side effects is consistent with patient guidance.


Q: Does Tetra Cortisone interact with common supplements like vitamin D or magnesium?

Yes, regulatory information indicates interactions with supplements containing certain minerals.

Supplements containing calcium, iron, magnesium, or zinc may bind to the Tetracycline component, potentially reducing the absorption and effectiveness of the antibiotic. Regulatory guidance on these interactions often suggests the separation of administration times.


Q: Is there a generic version of Tetra Cortisone available?

The individual active ingredients, Hydrocortisone and Tetracycline, are both widely available in generic versions.

Generic versions are required by regulatory bodies to contain the same active ingredients. Availability of a generic for the specific combination product is determined by regulatory approval in each specific region.


Q: Is it true that Tetra Cortisone can affect sleep?

Insomnia (difficulty sleeping) is listed as a possible side effect associated with the Hydrocortisone component.

The natural hormone cortisol, which is similar to hydrocortisone, plays a key role in the body's sleep-wake cycle, and its use can influence these patterns.


Q: Can I drive or operate machinery while using Tetra Cortisone?

Neurological side effects, including dizziness and vertigo, are listed in prescribing information for the systemic Hydrocortisone component.

Official information indicates that if neurological side effects occur, caution regarding activities like driving or operating machinery may be necessary.


Q: Is Tetra Cortisone known to interact with birth control pills?

Yes, regulatory information documents a potential interaction with oral contraceptives.

Concomitant use of the Tetracycline component is documented in regulatory information as potentially rendering some oral contraceptives less effective.


Q: Is it common to feel more emotional or anxious when starting Tetra Cortisone?

Changes in mood and behavior, including depression and increased anxiety or emotional volatility, are documented as possible neurological side effects of the Hydrocortisone component.

Official information notes potential mood changes associated with systemic corticosteroid exposure.


Q: Does research show that Tetra Cortisone is effective for its labeled uses?

The overall evidence supporting the research context of this combination is categorized in systematic reviews as Moderate.

Existing research involves short-term studies examining the combination in conditions characterized by infected inflammatory skin conditions.


Q: Can I use Tetra Cortisone if I have a history of stomach ulcers?

Prescribing information for the systemic Hydrocortisone component lists serious gastrointestinal effects, including the potential for peptic ulceration and hemorrhage.

This risk factor is part of the clinical considerations for the use of the product.


Q: Will taking Tetra Cortisone impact my regular blood tests?

Yes, regulatory documents note that the drug components can influence certain blood markers.

The Hydrocortisone component can cause fluid and electrolyte disturbances, such as potassium loss. Additionally, the Tetracycline component can increase BUN levels and requires monitoring of blood work for long-term use.


Q: Can I use Tetra Cortisone if I have kidney problems?

The use of certain tetracycline combinations is cautioned for patients with severe kidney disease. Furthermore, the prescribing information notes a risk of fatal renal toxicity when the tetracycline component is combined with Methoxyflurane.

Due to potential risks, any pre-existing kidney condition is a required consideration prior to the use of this product.


Q: What is the difference between brand-name Tetra Cortisone and its generic equivalent?

Generic versions are required by regulatory bodies to contain the exact same active ingredients (Hydrocortisone and Tetracycline) in the same strength as the brand name.

Differences primarily lie in the inactive ingredients used in the formulation, as well as the packaging and overall cost.


Q: Are there any known interactions between Tetra Cortisone and vaccines?

Yes, the Hydrocortisone component may decrease the body's immune response to certain vaccines.

If vaccinations are required while using the drug, official guidance recommends seeking advice to discuss timing and suitability.


Q: Can people with liver disease use Tetra Cortisone?

The risk of systemic effects, particularly the suppression of the Hypothalamic-Pituitary-Adrenal (HPA) axis from the corticosteroid component, is officially noted as being greater in patients with underlying Hepatic Impairment (liver disease).

Pre-existing liver conditions are a required consideration for the use of this medication.


Q: What are the most commonly reported side effects in research on Tetra Cortisone?

Based on frequency classification in regulatory documents, the most commonly reported effects occur at the application site.

These common local effects include burning, itching, irritation, dryness, and folliculitis.


Q: Does Tetra Cortisone have a 'Black Box Warning' in the US?

Regulatory documents for the systemic forms of the active ingredients, Hydrocortisone and Tetracycline, do not list a specific FDA Black Box Warning in their public summaries.

However, the medicine does carry warnings related to the potential for serious systemic side effects, especially with prolonged use.


Q: Is Tetra Cortisone used for acute or chronic conditions?

Official information indicates the combination product is primarily supported by research involving short-term use for episodes of increased symptom activity.

Risks of serious side effects, such as skin thinning or HPA-axis suppression, are documented as being associated with prolonged or long-term use.


Q: What is the recommended storage temperature for Tetra Cortisone?

The official requirement is to store the product at Controlled Room Temperature.

This temperature is typically defined as 20 C to 25 C (68 F to 77 F). The product must also be protected from freezing, excessive heat, moisture, and direct light.


Q: What is the purpose of the 'inactive ingredients' listed for Tetra Cortisone?

Inactive ingredients, also known as excipients, are included in the product for various technical and stability reasons.

They help to stabilize the product, aid in manufacturing, and ensure the active ingredients can be properly administered to the body. For example, in oral forms, substances like corn starch or lactose are used to form the tablets.

Advertisements

How should Tetra Cortisone be stored and disposed of?

How to Store and Dispose of Tetra Cortisone?

Official regulatory information defines mandatory conditions for storing and disposing of this topical combination product.

️ Storage Requirements

Storage Focus Official Requirement
Temperature Store at Controlled Room Temperature, typically 20 C to 25 C.
Container Keep the product in its original container and maintain it tightly closed.
Protection Keep from freezing and protect against excessive heat, moisture, and direct light.

Child Safety and Disposal

It is a mandatory requirement to store the medicine out of the sight and reach of children, often defined as a high or locked location. Do not keep outdated or unused medicine. Disposal of the expired or unwanted product must be carried out in accordance with local pharmaceutical waste requirements; patients should consult a healthcare professional for specific guidance on disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tetra Cortisone found in:

A-Z Index: